![]() |
||||||
|
![]() | |
![]() | |
![]() | Differntial gene expression between RNA A-to-I edited tumor samples versus normal samples |
![]() | |
![]() | |
![]() | The effects of the RNA editing to the stability of the RNA structures |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Editing gene: ERCC4 (CAeditome ID:2072) |
Gene summary for ERCC4 |
![]() |
Gene information | Gene symbol | ERCC4 | Gene ID | 2072 |
Gene name | ERCC excision repair 4, endonuclease catalytic subunit | |
Synonyms | ERCC11|FANCQ|RAD1|XFEPS|XPF | |
Cytomap | 16p13.12 | |
Type of gene | protein-coding | |
Description | DNA repair endonuclease XPFDNA excision repair protein ERCC-4DNA repair protein complementing XP-F cellsexcision repair cross-complementation group 4excision repair cross-complementing rodent repair deficiency, complementation group 4excision-repair, | |
Modification date | 20210531 | |
UniProtAcc | Q92889 | |
Context | - 33490679(The ECCR1 rs11615, ERCC4 rs2276466, XPC rs2228000 and XPC rs2228001 polymorphisms increase the cervical cancer risk and aggressiveness in the Bangladeshi population) |
![]() |
Gene | GO ID | GO term | PubMed ID |
ERCC4 | GO:0010521 | DNA repair endonuclease XPF | 18812185 |
ERCC4 | GO:0051974 | DNA repair endonuclease XPF | 18812185 |
ERCC4 | GO:0006289 | DNA repair endonuclease XPF | 10644440 |
ERCC4 | GO:0003677 | DNA repair endonuclease XPF | 14734547 |
ERCC4 | GO:0004520 | DNA repair endonuclease XPF | 8797827 |
ERCC4 | GO:0003697 | DNA repair endonuclease XPF | 10413517 |
ERCC4 | GO:0004520 | DNA repair endonuclease XPF | 10413517 |
ERCC4 | GO:0004520 | DNA repair endonuclease XPF | 14734547 |
ERCC4 | GO:0033683 | DNA repair endonuclease XPF | 10413517 |
ERCC4 | GO:1904357 | DNA repair endonuclease XPF | 18812185 |
ERCC4 | GO:1905768 | DNA repair endonuclease XPF | 18812185 |
ERCC4 | GO:0000781 | DNA repair endonuclease XPF | 14690602 |
ERCC4 | GO:0000781 | DNA repair endonuclease XPF | 14690602 |
ERCC4 | GO:0005634 | DNA repair endonuclease XPF | 12571280 |
ERCC4 | GO:0000109 | DNA repair endonuclease XPF | 10644440 |
ERCC4 | GO:0000110 | DNA repair endonuclease XPF | 10413517 |
ERCC4 | GO:0070522 | DNA repair endonuclease XPF | 14690602 |
ERCC4 | GO:0070522 | DNA repair endonuclease XPF | 17055345 |
Top |
RNA A-to-I events for ERCC4 |
![]() |
![]() |
![]() |
![]() |
![]() |
CAediting_1090018(13927304, +), CAediting_1090019(13936947, +), CAediting_1090020(13937039, +), CAediting_1090021(13937177, +), CAediting_1090022(13948558, +), CAediting_1090023(13948576, +), CAediting_1090024(13948579, +), CAediting_1090025(13948591, +), CAediting_1090026(13948592, +), CAediting_1090027(13948593, +), CAediting_1090028(13948596, +), CAediting_1090029(13948605, +), CAediting_1090030(13948617, +), CAediting_1090031(13948639, +), CAediting_1090032(13948645, +), CAediting_1090033(13948646, +), CAediting_1090034(13948652, +), CAediting_1090035(13948657, +), CAediting_1090036(13948662, +), CAediting_1090037(13948665, +), CAediting_1090038(13948676, +), CAediting_1090039(13948679, +), CAediting_1090040(13948680, +), CAediting_1090041(13948686, +), CAediting_1090042(13948691, +), CAediting_1090043(13948692, +), CAediting_1090044(13948711, +), CAediting_1090045(13948715, +), CAediting_1090046(13948721, +), CAediting_1090047(13948722, +), CAediting_1090048(13948727, +), CAediting_1090049(13948734, +), CAediting_1090050(13949343, +), CAediting_1090051(13949347, +), CAediting_1090052(13949352, +), CAediting_1090053(13949359, +), CAediting_1090054(13949386, +), CAediting_1090055(13950012, +), CAediting_1090056(13950017, +), CAediting_1090057(13950025, +), CAediting_1090058(13950061, +), CAediting_1090059(13950100, +), CAediting_1090060(13950148, +), CAediting_1090061(13950186, +), CAediting_1090062(13950200, +), |
Top |
RNA editing positional annotations for ERCC4 using Annovar |
![]() |
CAeditome ID | Position | Variant type | ENST | NTchange | AAchange | SIFT_score | Polyphen2_HVAR_score | PROVEAN_pred |
![]() |
CAeditome ID | Position | Variant type |
CAediting_1090018 | chr16_13927304_+ | intronic |
CAediting_1090019 | chr16_13936947_+ | ncRNA_intronic |
CAediting_1090020 | chr16_13937039_+ | ncRNA_intronic |
CAediting_1090021 | chr16_13937177_+ | ncRNA_intronic |
CAediting_1090022 | chr16_13948558_+ | UTR3 |
CAediting_1090023 | chr16_13948576_+ | UTR3 |
CAediting_1090024 | chr16_13948579_+ | UTR3 |
CAediting_1090025 | chr16_13948591_+ | UTR3 |
CAediting_1090026 | chr16_13948592_+ | UTR3 |
CAediting_1090027 | chr16_13948593_+ | UTR3 |
CAediting_1090028 | chr16_13948596_+ | UTR3 |
CAediting_1090029 | chr16_13948605_+ | UTR3 |
CAediting_1090030 | chr16_13948617_+ | UTR3 |
CAediting_1090031 | chr16_13948639_+ | UTR3 |
CAediting_1090032 | chr16_13948645_+ | UTR3 |
CAediting_1090033 | chr16_13948646_+ | UTR3 |
CAediting_1090034 | chr16_13948652_+ | UTR3 |
CAediting_1090035 | chr16_13948657_+ | UTR3 |
CAediting_1090036 | chr16_13948662_+ | UTR3 |
CAediting_1090037 | chr16_13948665_+ | UTR3 |
CAediting_1090038 | chr16_13948676_+ | UTR3 |
CAediting_1090039 | chr16_13948679_+ | UTR3 |
CAediting_1090040 | chr16_13948680_+ | UTR3 |
CAediting_1090041 | chr16_13948686_+ | UTR3 |
CAediting_1090042 | chr16_13948691_+ | UTR3 |
CAediting_1090043 | chr16_13948692_+ | UTR3 |
CAediting_1090044 | chr16_13948711_+ | UTR3 |
CAediting_1090045 | chr16_13948715_+ | UTR3 |
CAediting_1090046 | chr16_13948721_+ | UTR3 |
CAediting_1090047 | chr16_13948722_+ | UTR3 |
CAediting_1090048 | chr16_13948727_+ | UTR3 |
CAediting_1090049 | chr16_13948734_+ | UTR3 |
CAediting_1090050 | chr16_13949343_+ | UTR3 |
CAediting_1090051 | chr16_13949347_+ | UTR3 |
CAediting_1090052 | chr16_13949352_+ | UTR3 |
CAediting_1090053 | chr16_13949359_+ | UTR3 |
CAediting_1090054 | chr16_13949386_+ | UTR3 |
CAediting_1090055 | chr16_13950012_+ | UTR3 |
CAediting_1090056 | chr16_13950017_+ | UTR3 |
CAediting_1090057 | chr16_13950025_+ | UTR3 |
CAediting_1090058 | chr16_13950061_+ | UTR3 |
CAediting_1090059 | chr16_13950100_+ | UTR3 |
CAediting_1090060 | chr16_13950148_+ | UTR3 |
CAediting_1090061 | chr16_13950186_+ | UTR3 |
CAediting_1090062 | chr16_13950200_+ | UTR3 |
![]() |
CAeditome ID | Position | Repeat family | Repeat sub family | Repeat name |
CAediting_1090018 | chr16_13927304_+ | SINE | Alu | AluSx |
CAediting_1090019 | chr16_13936947_+ | SINE | Alu | AluJb |
CAediting_1090020 | chr16_13937039_+ | SINE | Alu | AluJb |
CAediting_1090021 | chr16_13937177_+ | SINE | Alu | AluJb |
CAediting_1090050 | chr16_13949343_+ | SINE | Alu | AluSz6 |
CAediting_1090051 | chr16_13949347_+ | SINE | Alu | AluSz6 |
CAediting_1090052 | chr16_13949352_+ | SINE | Alu | AluSz6 |
CAediting_1090053 | chr16_13949359_+ | SINE | Alu | AluSz6 |
CAediting_1090054 | chr16_13949386_+ | SINE | Alu | AluSz6 |
CAediting_1090055 | chr16_13950012_+ | SINE | Alu | AluSx |
CAediting_1090056 | chr16_13950017_+ | SINE | Alu | AluSx |
CAediting_1090057 | chr16_13950025_+ | SINE | Alu | AluSx |
CAediting_1090058 | chr16_13950061_+ | SINE | Alu | AluSx |
CAediting_1090059 | chr16_13950100_+ | SINE | Alu | AluSx |
CAediting_1090060 | chr16_13950148_+ | SINE | Alu | AluSx |
CAediting_1090061 | chr16_13950186_+ | SINE | Alu | AluSx |
CAediting_1090062 | chr16_13950200_+ | SINE | Alu | AluSx |
Top |
RNA A-to-I editing events in the alternative splicing sites for ERCC4 |
![]() |
AStype | CAeditomID | Editing position | AS position | AS direction | Exonic location | Wildtype sequence | Wildtype splicing strength | RNA edited sequence | RNA edited splicing strength |
![]() |
![]() |
Top |
Differntial gene expression between RNA A-to-I edited versus non-edited samples for ERCC4 |
![]() * The grey color means N/A. |
![]() |
![]() |
![]() |
![]() * Click on the image to enlarge it in a new window. |
Top |
Protein coding region RNA A-to-I editings for ERCC4 |
![]() * Click on the image to enlarge it in a new window. |
Top |
The effects of the RNA editing to the miRNA binding sites for ERCC4 |
**If you are searching a miRNA gene with RNA editing events in its seed regions, please see the search pages of miRNA targets to discover the effects of this RNA editing event to miRNA regulations. For more information, please check the files in the Download page. |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
CAediting_1351755 | chr19_40282625_- | ENSG00000175595.13 | ENST00000575156 | hsa-miR-641 | 13933213 | 13933219 | 7mer-1a | 13933193 | 13933219 | 144 | -23.93 |
![]() |
CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
![]() |
Top |
The effects of the RNA editing to the stability of the RNA structures for ERCC4 |
![]() * Click on the image to enlarge it in a new window. |
ENST | ENST type | RNA structure without RNA A-to-I editing. | RNA structure with RNA A-to-I editing. |
![]() |
CAeditom_ID | ENST | Editing_Position | MFE_withoneAI | MFE_withoutAI | MFE_withmultipleAI |
Top |
Relation with ADAR for ERCC4 |
![]() |
Cancer | CAeditomID | position | ADAR1 (p-val) | ADAR1 (coeff.) | ADAR2 (p-val) | ADAR2 (coeff.) | ADAR3 (p-val) | ADAR3 (coeff.) |
BRCA | CAediting_1090022 | chr16_13948558_+ | 7.66487776145431e-09 | 0.308080113793209 | . | . | . | . |
LGG | CAediting_1090023 | chr16_13948576_+ | 0.00729011479189209 | 0.229975630444926 | . | . | . | . |
BRCA | CAediting_1090023 | chr16_13948576_+ | 3.83462583729071e-20 | 0.492971938543607 | . | . | . | . |
LUSC | CAediting_1090023 | chr16_13948576_+ | 0.00524589848727258 | 0.385231968012111 | . | . | . | . |
HNSC | CAediting_1090023 | chr16_13948576_+ | 1.29495723787225e-06 | 0.574408752858207 | . | . | . | . |
SKCM | CAediting_1090023 | chr16_13948576_+ | 2.26639056325675e-05 | 0.496190814557823 | . | . | . | . |
LGG | CAediting_1090026 | chr16_13948592_+ | . | . | 0.0150190572437669 | 0.315235390019101 | . | . |
BRCA | CAediting_1090026 | chr16_13948592_+ | 0.000999877829985981 | 0.233869107257438 | 0.0403907197096016 | 0.146931305876996 | . | . |
KIRC | CAediting_1090026 | chr16_13948592_+ | . | . | 1.06509807212216e-06 | 0.612989632820165 | . | . |
BRCA | CAediting_1090027 | chr16_13948593_+ | 0.000601158665566326 | 0.255415182900966 | . | . | . | . |
BRCA | CAediting_1090028 | chr16_13948596_+ | 5.98520954418863e-05 | 0.314644131266757 | . | . | . | . |
BRCA | CAediting_1090037 | chr16_13948665_+ | 0.00163560894551254 | 0.32051723427096 | . | . | . | . |
LGG | CAediting_1090038 | chr16_13948676_+ | 0.0101014733318014 | 0.286061226934409 | . | . | . | . |
BRCA | CAediting_1090038 | chr16_13948676_+ | 4.50604185560213e-07 | 0.328148808395757 | . | . | . | . |
OV | CAediting_1090038 | chr16_13948676_+ | 0.0304152881504193 | 0.240708439793681 | . | . | . | . |
LGG | CAediting_1090040 | chr16_13948680_+ | 0.000802451870323749 | 0.358842905816252 | . | . | . | . |
BRCA | CAediting_1090040 | chr16_13948680_+ | 3.40518131945085e-16 | 0.497989770980038 | . | . | . | . |
OV | CAediting_1090040 | chr16_13948680_+ | 1.9055776849342e-05 | 0.448229988155601 | . | . | . | . |
LGG | CAediting_1090042 | chr16_13948691_+ | 5.77516395207018e-05 | 0.404540529226766 | . | . | . | . |
BRCA | CAediting_1090042 | chr16_13948691_+ | 2.47288764138849e-18 | 0.488681834191433 | . | . | . | . |
LUSC | CAediting_1090042 | chr16_13948691_+ | 0.00444141159927773 | 0.388353882035371 | . | . | . | . |
HNSC | CAediting_1090042 | chr16_13948691_+ | 0.00106954566568862 | 0.422226688828811 | . | . | . | . |
OV | CAediting_1090042 | chr16_13948691_+ | 1.07490660770449e-06 | 0.503103488574 | . | . | . | . |
BRCA | CAediting_1090043 | chr16_13948692_+ | . | . | 0.000871321369814546 | 0.201455126537235 | . | . |
HNSC | CAediting_1090043 | chr16_13948692_+ | . | . | 0.00169584602669556 | 0.406640448299344 | . | . |
KIRC | CAediting_1090043 | chr16_13948692_+ | . | . | 0.00304863750035131 | 0.399408800841722 | . | . |
SKCM | CAediting_1090043 | chr16_13948692_+ | . | . | 1.18079569422064e-06 | 0.592833083378478 | . | . |
BRCA | CAediting_1090053 | chr16_13949359_+ | 0.00647446497171282 | 0.172122545055615 | . | . | . | . |
Top |
Relation with cancer stages for ERCC4 |
![]() |
Cancer | Stage_type | CAeditomID | position | P-val | Coeff. |
BRCA | pathologic_stage | CAediting_1090028 | chr16_13948596_+ | 0.0485897409640096 | 0.161320546388231 |
BRCA | pathologic_stage | CAediting_1090043 | chr16_13948692_+ | 0.012044556367185 | 0.154629029488154 |
Top |
Relation with survival for ERCC4 |
![]() |
Cancer | CAeditomID | position | KMpvalue | Coxpvalue | CoxHR |
Top |
RelatedDrugs for ERCC4 |
![]() (DrugBank Version 5.1.8 2021-01-03) |
Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ERCC4 |
![]() (DisGeNet 7.0) |
Gene | Disease ID | Disease name | # pubmeds | Source |
ERCC4 | C0268140 | Xeroderma pigmentosum, group F | 10 | CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT |
ERCC4 | C3808988 | FANCONI ANEMIA, COMPLEMENTATION GROUP Q | 5 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
ERCC4 | C1970416 | XFE Progeroid Syndrome | 3 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
ERCC4 | C0015625 | Fanconi Anemia | 2 | GENOMICS_ENGLAND;ORPHANET |
ERCC4 | C1449861 | Micronuclei, Chromosome-Defective | 2 | CTD_human |
ERCC4 | C1449862 | Micronuclei, Genotoxicant-Induced | 2 | CTD_human |
ERCC4 | C0005684 | Malignant neoplasm of urinary bladder | 1 | CTD_human |
ERCC4 | C0005695 | Bladder Neoplasm | 1 | CTD_human |
ERCC4 | C0023465 | Acute monocytic leukemia | 1 | GENOMICS_ENGLAND |
ERCC4 | C0023467 | Leukemia, Myelocytic, Acute | 1 | GENOMICS_ENGLAND |
ERCC4 | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
ERCC4 | C0027654 | Embryonal Neoplasm | 1 | CTD_human |
ERCC4 | C0027658 | Neoplasms, Germ Cell and Embryonal | 1 | CTD_human |
ERCC4 | C0039590 | Testicular Neoplasms | 1 | CTD_human |
ERCC4 | C0153594 | Malignant neoplasm of testis | 1 | CTD_human |
ERCC4 | C0205851 | Germ cell tumor | 1 | CTD_human |
ERCC4 | C0205852 | Neoplasms, Embryonal and Mixed | 1 | CTD_human |
ERCC4 | C0265219 | Miller Dieker syndrome | 1 | GENOMICS_ENGLAND |
ERCC4 | C0274861 | Arsenic Poisoning, Inorganic | 1 | CTD_human |
ERCC4 | C0274862 | Nervous System, Organic Arsenic Poisoning | 1 | CTD_human |
ERCC4 | C0311375 | Arsenic Poisoning | 1 | CTD_human |
ERCC4 | C0740345 | Germ Cell Cancer | 1 | CTD_human |
ERCC4 | C0751039 | Cockayne Syndrome, Type I | 1 | ORPHANET |
ERCC4 | C0751364 | Cancer, Embryonal | 1 | CTD_human |
ERCC4 | C0751365 | Cancer, Embryonal and Mixed | 1 | CTD_human |
ERCC4 | C0751851 | Arsenic Encephalopathy | 1 | CTD_human |
ERCC4 | C0751852 | Arsenic Induced Polyneuropathy | 1 | CTD_human |
ERCC4 | C1720811 | Tumor of Rete Testis | 1 | CTD_human |
ERCC4 | C3463824 | MYELODYSPLASTIC SYNDROME | 1 | GENOMICS_ENGLAND |
ERCC4 | C4228778 | Abnormality of radial ray | 1 | GENOMICS_ENGLAND |
ERCC4 | C4721453 | Peripheral Nervous System Diseases | 1 | CTD_human |